PASSAGE BIO INC (PASG) Forecast, Price Target & Analyst Ratings

NASDAQ:PASG • US7027122099

Current stock price

7.095 USD
+0.4 (+6.05%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PASSAGE BIO INC (PASG).

Forecast Snapshot

Consensus Price Target

Price Target
$40.39
+ 469.30% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$2.61
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$40.39
Upside
+ 469.30%
From current price of $7.10 to mean target of $40.39, Based on 12 analyst forecasts
Low
$10.10
Median
$32.64
High
$71.40

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for PASG. The average price target is 40.39 USD. This implies a price increase of 469.3% is expected in the next year compared to the current price of 7.095.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PASG Current Analyst RatingPASG Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

PASG Historical Analyst RatingsPASG Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
PASG was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PASG.
In the previous month the buy percentage consensus was at a similar level.
PASG was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-04Canaccord GenuityMaintains Buy -> Buy
2025-11-12Chardan CapitalMaintains Buy -> Buy
2025-08-14GuggenheimMaintains Buy -> Buy
2025-08-14Canaccord GenuityMaintains Buy -> Buy
2025-08-13WedbushMaintains Outperform -> Outperform
2025-06-24Chardan CapitalMaintains Buy -> Buy
2025-03-04Chardan CapitalMaintains Buy -> Buy
2024-11-14Chardan CapitalMaintains Buy -> Buy
2024-11-14Canaccord GenuityMaintains Buy -> Buy
2024-09-03Rodman & RenshawInitiate Buy
2024-05-15Canaccord GenuityMaintains Buy -> Buy
2024-03-05Canaccord GenuityReiterate Buy -> Buy
2023-11-14Raymond JamesMaintains Outperform -> Outperform
2023-08-08Chardan CapitalMaintains Buy -> Buy
2023-05-12Raymond JamesMaintains Outperform -> Outperform
2022-12-15Chardan CapitalMaintains Buy
2022-11-11GuggenheimMaintains Buy
2022-11-11CitigroupMaintains Buy
2022-11-08Canaccord GenuityInitiate Buy
2022-05-17Raymond JamesMaintains Outperform
2022-05-17CitigroupMaintains Buy
2022-03-08JP MorganDowngrade Overweight -> Neutral
2022-03-04Raymond JamesMaintains Outperform
2022-01-19Goldman SachsDowngrade Buy -> Neutral
2021-07-01Raymond JamesInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$2.61
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
47.78%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-35.81%
EPS (3 Months)
-35.81%

Next Earnings Summary

PASG is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -2.61 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PASG revenue by date.PASG revenue by date.
N/AN/AN/AN/AN/A
111.50%		N/A
-44.82%		N/A
124.13%		N/A
71.38%
EBITDA
YoY % growth
PASG ebitda by date.PASG ebitda by date.
-13.47M-37.06M
-175.13%		-112.1M
-202.48%		-184.19M
-64.31%		-134.71M
26.86%		-99.278M
26.30%		-62.086M
37.46%		-42.423M
31.67%		N/A
-80.48%		N/A
27.37%		N/A
119.54%		N/A
458.92%		N/A
129.67%		N/A
34.02%		N/AN/A
EBIT
YoY % growth
PASG ebit by date.PASG ebit by date.
-13.47M-37.19M
-176.10%		-112.9M
-203.58%		-185.73M
-64.51%		-138.39M
25.49%		-102.999M
25.57%		-65.167M
36.73%		-43.151M
33.78%		N/A
-3.94%		N/A
-2.75%		N/A
-1.27%		N/A
177.51%		N/A
270.52%		N/A
-82.82%		N/A
221.46%		N/A
142.19%
Operating Margin
PASG operating margin by date.PASG operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
PASG eps by date.PASG eps by date.
N/AN/A-61.60-69.60
-12.99%		-50.00
28.16%		-37.20
25.60%		-21.40
42.47%		-14.35
32.94%		N/A
64.89%		N/A
27.80%		N/A
88.22%		N/A
1,812.69%		N/A
119.51%		N/A
-93.48%		N/A
-116.50%		N/A
935.29%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-2.61
47.78%		-1.58
46.76%		-1.64
32.91%		-1.69
57.26%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-10.518M
23.90%		-10.506M
-1.66%		-11.118M
-28.46%		-11.679M
-12.95%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PASG Yearly Revenue VS EstimatesPASG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 100M 200M 300M 400M
PASG Yearly EPS VS EstimatesPASG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40 -60

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.36%
EPS Next 5 Year
25.57%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
30.90%
EBIT Next 5 Year
38.63%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PASSAGE BIO INC / PASG Forecast FAQ

Can you provide the average price target for PASSAGE BIO INC stock?

12 analysts have analysed PASG and the average price target is 40.39 USD. This implies a price increase of 469.3% is expected in the next year compared to the current price of 7.095.

Can you provide the upcoming earnings date for PASSAGE BIO INC?

PASSAGE BIO INC (PASG) will report earnings on 2026-05-11.

What are the consensus estimates for PASG stock next earnings?

The consensus EPS estimate for the next earnings of PASSAGE BIO INC (PASG) is -2.61 USD and the consensus revenue estimate is 0 USD.

Can you provide the analyst count for PASSAGE BIO INC stock?

The number of analysts covering PASSAGE BIO INC (PASG) is 12.